TMC Life Sciences

Equities

TMCLIFE

MYQ0101OO004

Healthcare Facilities & Services

End-of-day quote BURSA MALAYSIA Other stock markets 06:00:00 2024-07-16 pm EDT			5-day change	1st Jan Change
0.645 ^MYR	-1.53%		-0.77%	-9.79%

May. 24	TMC Life Sciences’ Attributable Profit for Fiscal Q3 Shrinks	MT
May. 23	TMC Life Sciences Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI

TMC Life Sciences Berhad Announces the Redesignation of Gary Ho Kuat Foong from Non Independent and Non Executive Chairman of Risk Committee to Non Independent and Non Executive Member of Risk Committee Effective January 12, 2020

January 09, 2020

TMC Life Sciences Berhad announced the redesignation of Gary Ho Kuat Foong from Non Independent and Non Executive Chairman of Risk Committee to Non Independent and Non Executive Member of Risk Committee. The date of change is January 12, 2020.

Latest news about TMC Life Sciences

TMC Life Sciences’ Attributable Profit for Fiscal Q3 Shrinks	May. 24	MT
TMC Life Sciences Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	May. 23	CI
TMC Life Sciences Unit, Oncocare Medical Extend Term of LOI	May. 22	MT
TMC Life Sciences' Profit More Than Doubles in Fiscal Q2	Feb. 04	MT
TMC Life Sciences Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 02	CI
TMC Life Sciences Suspends Group CEO	Jan. 29	MT
TMC Life Sciences Berhad Announces Suspension of Puan Wan Nadiah Binti Wan Mohd Abdullah Yaakob as Group Chief Executive Officer	Jan. 29	CI
TMC Life Sciences Berhad Announces Redesignation of Dr Heng Jun Li Melvin from Non Executive Director to Group Chief Executive Officer	Jan. 29	CI
TMC Life Sciences' Profit, Revenue Rise in Fiscal Q1	Nov. 15	MT
TMC Life Sciences Berhad Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 14	CI
TMC Life Sciences Berhad Announces CFO Changes	Nov. 09	CI
TMC Life Sciences Berhad Announces Redesignation of Kan Kheong Ng as Executive Vice Chairman	Nov. 09	CI
Tmc Life Sciences Berhad Proposes Single-Tier Final Dividend Per Ordinary Share for the Financial Year Ended 30 June 2023, Payable on 03 January 2024	23-08-22	CI
TMC Life Sciences Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2023	23-08-22	CI
Tmc Life Sciences Berhad Proposes Special Single-Tier Dividend, Payable on 03 January 2024	23-08-22	CI
Tmc Life Sciences Berhad Announces Appointment of Mohd Sheridan Bin Ramli as Independent and Non Executive Member of Risk Committee	23-07-14	CI
Tmc Life Sciences Berhad Announces Appointment of Mohd Sheridan Bin Ramli as Independent and Non Executive Member of Nomination Committee	23-07-14	CI
Tmc Life Sciences Berhad Announces Appointment Mohd Sheridan Bin Ramli as Independent and Non Executive Member of Remuneration Committee	23-07-14	CI
Tmc Life Sciences Berhad Announces Appointment of Dato' Mohd Sheridan Bin Ramli as Independent and Non Executive Director	23-07-14	CI
Tmc Life Sciences Berhad Announces Appointment of Dato' Mohd Sheridan Bin Ramli as Independent and Non Executive Member of Audit Committee	23-07-14	CI
TMC Life Sciences Berhad Announces Redesignation of Cheah Ho Chee as Independent and Non Executive Chairman of Risk Committee from Member of Risk Committee	23-05-31	CI
TMC Life Sciences Berhad Announces Resignation of Gary Ho Kuat Foong as Independent and Non Executive Independent Director	23-05-31	CI
TMC Life Sciences Berhad Announces Appointment of Puan Mazrina Binti Arifin as Independent and Non Executive Member of Risk Committee	23-05-31	CI
TMC Life Sciences Berhad Announces Cessation of Office of Gary Ho Kuat Foong as Independent and Non Executive Member of Risk Committee	23-05-31	CI
Tmc Life Sciences Berhad Announces Resignation of Datin Sri Claire Lee Suk Leng as Independent and Non Executive Independent Director	23-05-31	CI

Chart TMC Life Sciences

Duration

Period

More charts

Company Profile

TMC Life Sciences Berhad is a Malaysia-based investment holding company. The Companyâs segments include Thomson Hospitals Sdn. Bhd., IVF Technologies Sdn. Bhd., TMC Lifestyle Sdn. Bhd., TMC Properties Sdn. Bhd., Thomson TCM Sdn. Bhd., BB Waterfront Sdn. Bhd., TMC Care Sdn. Bhd. and others. Thomson Hospitals Sdn. Bhd provides multi-disciplinary tertiary care services. IVF Technologies Sdn. Bhd. provides fertility services and operation of womenâs clinic. TMC Lifestyle Sdn. Bhd. is engaged in the development, marketing and management of healthcare programs, and provision of fertility consultancy, laboratory and embryology services and research and development. TMC Properties Sdn. Bhd. is involved in property investment. Thomson TCM Sdn. Bhd. is involved in the provision of traditional and complementary services. BB Waterfront Sdn. Bhd. is involved in the provision of healthcare services. TMC Care Sdn. Bhd. offers pharmacy services and products, and management support services.

Sector

Healthcare Facilities & Services

Calendar

2024-08-19 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Hospitals, Clinics & Primary Care Services

	1st Jan change	Capi.
TMC LIFE SCIENCES	-9.79%	241M
AIER EYE HOSPITAL GROUP CO., LTD.	-31.73%	13.83B
IHH HEALTHCARE	+5.31%	11.99B
BANGKOK DUSIT MEDICAL SERVICES	-5.41%	11.61B
APOLLO HOSPITALS ENTERPRISE LIMITED	+14.32%	11.1B
ENCOMPASS HEALTH CORPORATION	+30.16%	8.74B
THE ENSIGN GROUP, INC.	+23.45%	7.82B
RAMSAY HEALTH CARE LIMITED	-9.47%	7.32B
MOUWASAT MEDICAL SERVICES COMPANY	+8.77%	6.51B
FORTIS HEALTHCARE LIMITED	+16.46%	4.42B

Hospitals, Clinics & Primary Care Services